Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Frontiers in Plant Science|February 21, 2024
Partial root-zone drying subsurface drip irrigation increased the alfalfa quality yield but decreased the alfalfa quality contentYadong Wang, Chong Xu, Qian Gu, et al.
ACS Applied Materials & Interfaces|June 27, 2019
Synergistically Improved Electronic and Thermal Transport Properties in Nb-Doped NbMo1-Se2-2Te2 Solid Solutions Due to Alloy Phonon Scattering and Increased Valley DegeneracyCheng Zhang, Zhi Li, Min Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 25, 2018
Adaptable Hydrogels Mediate Cofactor-Assisted Activation of Biomarker-Responsive Drug Delivery via Positive Feedback for Enhanced Tissue RegenerationKunyu Zhang, Zhaofeng Jia, Boguang Yang, et al.
Cell Biology International|October 26, 2017
Isolation and characterization of human mesenchymal stem cells derived from synovial fluid by magnetic-activated cell sorting (MACS)Zhaofeng Jia, Yujie Liang, Xiao Xu, et al.
Biomaterials|November 27, 2020
Exosome-mediated delivery of kartogenin for chondrogenesis of synovial fluid-derived mesenchymal stem cells and cartilage regenerationXiao Xu, Yujie Liang, Xingfu Li, et al.
International Journal of Rheumatic Diseases|January 23, 2018
A randomized multicenter clinical trial of 99 Tc-methylene diphosphonate in treatment of rheumatoid arthritisRong Mu, Jun Liang, Lingyun Sun, et al.
Modern Rheumatology|October 8, 2022
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analysesJie Zheng, Jieruo Gu, Yin Su, et al.
Rheumatology and Therapy|February 9, 2021
Safety and Efficacy of Prefilled Liquid Etanercept-Biosimilar Yisaipu for Active Ankylosing Spondylitis: A Multi-Center Phase III TrialDongbao Zhao, Dongyi He, Liqi Bi, et al.
RMD Open|April 16, 2022
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 yearsFengchun Zhang, Jie Zheng, Yang Li, et al.
Therapeutic Advances in Musculoskeletal Disease|May 7, 2021
Patient-reported outcomes from a randomized, double-blind, placebo controlled, phase III study of baricitinib versus placebo in patients with moderately to severely active rheumatoid arthritis and an inadequate response to methotrexate therapy: results from the RA-BALANCE studyYue Yang, Jianhua Xu, Jian Xu, et al.
Pageof 7